ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,010, issued on Aug. 12, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.) and The United States Government as represented by the Department of Veterans Affairs (Washington).
"Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes" was invented by Zurab Siprashvili (San Mateo, Calif.), Ngon T. Nguyen (Union City, Calif.), M. Peter Marinkovich (Redwood City, Calif.), Jean Tang (Stanford, Calif.), Alfred T. Lane (Los Altos, Calif.) and Paul A. Khavari (Palo Alto, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for the cel...